Nine of 11 patients with hepatoblastoma treated with cisplatin (DDP) based chemotherapy had a complete (CR) or partial (PR) remission. Five of these patients had measurable pulmonary disease and four achieved a CR of pulmonary lesions. The average interval of disease control following DDP was three times that of Adriamycin (ADR). DDP is an effective agent in the treatment of hepatoblastoma.
No takes yet. Share an insight, caveat, or question.
Douglass et al. (1985) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: